title: Patent foramen ovale and paradoxical thromboembolism. Which treatment is the most appropriate?
authors.affiliation: Division of Anesthesiology and Intensive Care, Hospital San Salvatore, Pesaro, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Masetti
authors.affiliation: Division of Anesthesiology and Intensive Care, Hospital San Salvatore, Pesaro, Italy.
authors.forename: Patrizia
authors.initials: P
authors.lastname: Borra
authors.affiliation: Division of Anesthesiology and Intensive Care, Hospital San Salvatore, Pesaro, Italy. Electronic address: salmaviglia@gmail.com.
authors.forename: Salvatore
authors.initials: S
authors.lastname: Maviglia
mesh_terms: D004452:Echocardiography; D005260:Female; D054092:Foramen Ovale, Patent / Q000150:complications / Q000000981:diagnostic imaging* / Q000628:therapy*; D006801:Humans; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D055989:Septal Occluder Device; D013923:Thromboembolism / Q000150:complications / Q000000981:diagnostic imaging* / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors
keywords: AMPLATZER PFO occluder; Cryptogenic stroke; PFO closure; Paradoxical embolism; Patent foramen ovale (PFO)